Provided by Tiger Trade Technology Pte. Ltd.

Skye Bioscience Inc.

0.2800
-0.0004-0.14%
Post-market: 0.2763-0.0037-1.30%19:49 EDT
Volume:974.58K
Turnover:263.16K
Market Cap:9.84M
PE:-0.22
High:0.2840
Open:0.2804
Low:0.2550
Close:0.2804
52wk High:4.99
52wk Low:0.2550
Shares:35.13M
Float Shares:22.95M
Volume Ratio:0.23
T/O Rate:4.25%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2800
EPS(LYR):-1.4100
ROE:-233.87%
ROA:-96.22%
PB:-19.78
PE(LYR):-0.20

Loading ...

NASDAQ Trade Halt Continues Halt News Pending at 03:28 Am

Reuters
·
Yesterday

Skye Bioscience Inc trading halted, news pending

TIPRANKS
·
Aug 22

5AM Partners VII Disposes of 375,840 Skye Bioscience Shares Worth $134,482.80

Reuters
·
Aug 21

Skye Bio Amends 8-K to Set Aug. 24 Effective Date for Reverse Stock Split

Reuters
·
Aug 20

Skye Bioscience Flags NASDAQ Noncompliance After Stockholders’ Equity Falls to ($497,307)

Reuters
·
Aug 19

Skye Bioscience Inc trading halted, news pending

TIPRANKS
·
Aug 16

NASDAQ Trade Halt Volatility Trading Pause at 10:00 Am

Reuters
·
Aug 14

Skye Bioscience: Qtrly EPS $-0.27 - SEC Filing

THOMSON REUTERS
·
Aug 14

Skye Bioscience Q2 2026 Operating Loss Narrows 39.37% to $11.06 Million

Reuters
·
Aug 14

Skye Bioscience to Acquire Redx Pharma, Rebrand as Fibrx Therapeutics on NASDAQ

Reuters
·
Aug 14

Skye Bioscience - Redx Enters Series a Financing Agreement for $36 Mln

THOMSON REUTERS
·
Aug 14

Skye Bioscience and Redx Pharma Announce Transaction Agreement and $125 Million in Financings

THOMSON REUTERS
·
Aug 14

Skye Bioscience - Holders to Receive CVR for 90% of Nimacimab Net Proceeds for 12 Months Post-Closing

THOMSON REUTERS
·
Aug 14

Skye Bioscience - Combined Company Cash Expected to Fund Operations into 2029 and Rxc008 Phase 2 Data in H2 2028

THOMSON REUTERS
·
Aug 14

Skye Bioscience - Post Deal Skye to Own 5.38% of Combined Co with Holding Redx 46.17%, Financing Investors 48.45%

THOMSON REUTERS
·
Aug 14

Skye Bioscience - Peter Collum to Serve as CFO of Fibrx Therapeutics

THOMSON REUTERS
·
Aug 14

Skye Bioscience - Combined Company to Operate as Fibrx Therapeutics and Trade on NASDAQ

THOMSON REUTERS
·
Aug 14

Skye Bioscience - to Buy Entire Issued Share Capital of Redx

THOMSON REUTERS
·
Aug 14

NASDAQ Trade Halt Halt News Pending at 08:39 Am

Reuters
·
Aug 14

Skye Bioscience Inc Expected to Post a Loss of 25 Cents a Share - Earnings Preview

Reuters
·
Aug 03